Vio/Cryo/Apc
Payments companies reported to CMS as associated with Vio/Cryo/Apc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vio/Cryo/Apc, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vio/Cryo/Apc
These are the largest totals companies reported as associated with Vio/Cryo/Apc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Abhinav Mittal | Tucson, AZ | Pulmonary Disease | $3,000.00 |
| Angela Argento | Baltimore, MD | Pulmonary Disease | $300.66 |
| Lonny Yarmus | Baltimore, MD | Pulmonary Disease | $274.81 |
| Victoria Gonzalez | Miami, FL | Pulmonary Disease | $274.81 |
| Gaurav Ajmani | Baltimore, MD | Pulmonary Disease | $274.81 |
| Andrew Demaio | Baltimore, MD | Pulmonary Disease | $186.17 |
| Jeffrey Thiboutot | Baltimore, MD | Internal Medicine | $186.17 |
| Van Holden | Baltimore, MD | Critical Care Medicine (Internal Medicine) | $160.32 |
| Robert Lentz | Nashville, TN | Pulmonary Disease | $160.32 |
| Ryan James | Fayetteville, AR | Pulmonary Disease | $160.32 |
Prescribed Vio/Cryo/Apc?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.